All SEC Filings :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

All SEC Filings

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
05/15/23	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			34
05/15/23	8-K	Current report filing Documents EX-99.1			11
04/11/23	DEF 14A	Definitive proxy statements			60
03/30/23	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-10.45 EX-10.46 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			68
03/29/23	8-K	Current report filing Documents EX-99.1			14
03/17/23	4	Statement of changes in beneficial ownership of securities			1
03/17/23	4	Statement of changes in beneficial ownership of securities			1
03/02/23	8-K	Current report filing Documents EX-99.1 EX-99.2 EX-99.3			118
11/14/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2			40
11/14/22	8-K	Current report filing Documents EX-99.1			12

1
2
3
4
5
6
7
8
9
10